SenseLab
Pathological mechanism
  Data
Glutamatergic synaptic depression by synthetic amyloid beta-peptide in the medial septum.
Glutamatergic synaptic depression by synthetic amyloid beta-peptide in the medial septum.Santos-Torres J, Fuente A, Criado JM, Riolobos AS, Heredia M, Yajeya J. BetaA effect was blocked by calcicludine (50 nM), a selective antagonist of L-type calcium channels, and also by blocking muscarinic receptors with atropine (5 muM) or pirenzepine (1 microM), a more specific M1-receptor blocker.
Other categories referring to Glutamatergic synaptic depression by synthetic amyloid beta-peptide in the medial septum.
Revisions: 3
Last Time: 11/21/2008 10:47:46 AM
Reviewer: Pradeep Mutalik
Owner: Pradeep Mutalik